Cost savings could include reductions in respiratory tract infections, antibiotic prescriptions, and sick days.
The ACIP has issued new guidelines for the prevention and control of seasonal influenza with vaccines for the 2019–2020 season.
Any form of licensed, age-appropriate influenza vaccine is acceptable, with no preferred formulation or product.
The two primary updates include the addition of hemagglutinin derived from an A/Brisbane/02/2018 (H1N1)pdm09-like virus, an A/Kansas/14/2017 (H3N2)-like virus, and a B/Colorado/06/2017-like virus (Victoria lineage) to the 2019 to 2020 US trivalent influenza vaccines.
Elderly patients who are vaccinated have lower risk for stroke and death in year following ICU discharge.
The FDA is warning consumers to stop using products known as Miracle or Master Mineral Solution due to numerous reports of significant health issues.
Providing educational intervention in waiting room before pediatric provider visit may be beneficial.
The peak level was significantly higher than the average during previous 5 influenza seasons,